Genetics and epigenetics of schizophrenia;Genetica ed epigenetica della schizofrenia

Clinica Terapeutica

Volumn 164, Issue SUPPL.4, 2013, Pages

  Fabi, Elisa ^a   Fusco, A ^b   Valiante, M ^b   Celli, R ^c  

^a Dipartimenti di Neurologia e Psichiatria   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

Epigenetics; Genetics; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; PROTEIN; PROTEIN GAD1; PROTEIN GRIA2; PROTEIN MARLIN 1; PROTEIN NR3B; PROTEIN RELN; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VESICULAR GLUTAMATE TRANSPORTER 1;

ARTICLE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 13; CHROMOSOME 14; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 22; CHROMOSOME 3; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 8; DNA SEQUENCE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; GENE IDENTIFICATION; GENETICS; HISTONE MODIFICATION; HUMAN; MEDLINE; MOLECULAR BIOLOGY; MONOZYGOTIC TWINS; NEUROTRANSMISSION; PATHOGENESIS; SCHIZOPHRENIA; GENETIC EPIGENESIS;

EPIGENESIS, GENETIC; HUMANS; SCHIZOPHRENIA;

EID: 84885773009     PISSN: 00099074     EISSN: 19726007     Source Type: Journal    
DOI: 10.7417/CT.2013.1596     Document Type: Article

References (51)

1. van Os J, Kapur S. Schizophrenia. Lancet 2009; 374: 635-45
2. Fleming MP, Martin CR. Genes and schizophrenia: A pseudoscientific disenfranchisement of the individual. J Psychiatr Ment Health Nurs 2011; 18:469-78
3. Corsico A, McGuffin P. Psychiatric genetics: recent advances and clinical implications. Epidemiol Psichiatria Sociale 2001; 10:253-9
4. Tsuang M. Schizophrenia: genes and environment. Biol Psychiat 2000; 47:210-20
5. Gottesman II, Erlenmeyer-Kimling L. Family and twin strategies as a head start indefining prodromes and endophenotypes for hypothetical early-interevntions in schizophrenia. Schizophr Res 2001; 51:93-102
6. Cannon TD, Kaprio J, Lonnqvist J, et al. The genetic epidemiology of schizophrenia in a Finnish twin cohort. Arch Gen Psychiat 1998; 55:67-74
7. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiat 2003; 60:1187-92
8. Tienari P, Wynne LC, Sorri A, et al. Genotype-environmentinteraction in schizophrenia-spectrum disorder: long-term follow-up study of Finnish adoptees. Br J Psychiat 2004; 184:216-22
9. Tienari P, Wynne LC, Moring J, et al. The Finnish Adoptive Family Study of Schizophrenia: implications for family research. Br J Psychiat 1994; 164:20-6
10. Wahlberg KE, Wynne LC, Oja H et al. Gene-environment interaction in vulnerability to schizophrenia: findings from the Finnish adoptive family study in schizophrenia. Am J Psychiat 1997; 154:355-62
11. Wahlberg KE, Wynne LC, Oja H. Thought disorder index of Finnish adoptees and communication deviance of their adoptive parents. Psychol Med 2000; 30:127-36
12. Olgiati P, Lorenzi C, Marino E, et al. Schizofrenia: genetica, prevenzione e riabilitazione. G It di Psicopatol 2008; 14: 108-33
13. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science 1997; 278:1580-1
14. Wang DG, Fan JB, Siao CJ, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in thehuman genome. Science 1998; 280:1077-82
15. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003; 33: 228-37
16. Levinson DF, Levinson MD, Segurado R, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part I: methods and power analysis. Am J Hum Genet 2003; 73: 17-33
17. Lewis CM, Levinson DF, Wise LH et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 2003; 73:17-33
18. Segurado R, Detera-Wadleigh SD, Levinson DF et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. Am J Hum Genet 2003; 73:34-48
19. Park N, Juo S, Liu J, al. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility loci for bipolar disorder and schizophrenia. In: Barden N, De Lisi L, Gill M, Kelsoe J, (Eds). Proceedings of the XI World Congress of Psychiatric Genetics, Quebec City 2003; 43
20. Prasad S, Semwal P, Deshpande et al. Molecular genetics of schizophrenia: past, present and future. J Biosci 2002; 27:35-52
21. Nurnberger JI Jr, Blehar MC, Kaufmann CA, et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH genetics initiative. Arch Gen Psychiat 1994; 51:849-59
22. Tsuang MT, Faraone SV, Fleming JA. Familial transmission of major affective disorders. Is there evidence supporting the distinction between unipolar and bipolar disorders? Br J Psychiat 1985; 146:268-71
23. Gebicke-Haerter PJ. Epigenetics of Schizophrenia. Pharmacopsychiatry 2012; 45:S42-8
24. Shi J, Levinson DF, Duan J, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460:753-7
25. Stefansson H, Ophoff RA, Steinberget S, al. Common variants conferring risk of schizophrenia. Nature 2009; 460:744-7
26. Girard SL, Dion PA, Rouleau GA. Schizophrenia Genetics: Putting All the Pieces Together; Curr Neurol Neurosci Rep 2012; 12:261-6
27. Gauthier J, Champagne N, Lafreniere RG, et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci USA 2010; 107:7863-8
28. Tarabeux J, Champagne N, Brustein E,. et al. De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry 2010; 68:649-56
29. Gauthier J, Siddiqui TJ, Huashan P, et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet 2011; 130:563-73
30. TJ. Crow TJ. How and why genetic linkage has not solved the problem of psychosis: review and hypothesis. Am J Psychiat 2007; 164:13-22
31. Chahrour M, Jung SY, Shaw C et al. Mecp2, a key contributor to neurological disease, activates and represses transcription. Science 2008; 320:1224-9
32. Cohen S, Zhou Z, Greenberg ME. Activating a repressor. Science 2008; 320:1172-3
33. Brooks PJ, Marietta C, Goldman D. DNA mismatch repair and DNA methylation in adult brain neurons. J Neurosci 1996; 16:939-45
34. Ravindran CRM, Ticku MK. Methylation of NMDA receptor nr2b gene as a function of age in the mouse brain. Neurosci 2005; 380:223-8 (Letter)
35. Levenson JM, Roth TL, Lubin FD, et al. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 2006; 281:15763-73
36. Lubin FD, Roth TL, Sweatt JD. Epigenetic regulation of bdnf gene transcription in the consolidation of fear memory. J Neurosci 2008; 28:10576-86
37. Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron 2007; 53:857-69
38. Nelson ED, Kavalali ET, Monteggia LM. Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J Neurosci 2008; 28:395-406
39. Mueller BR, Bale TL. Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci 2008; 28:9055-65
40. Roth TL, Lubin FD, Funk AJ, et al. Lasting epigenetic influence of earlylife adversity on the bdnf gene, Biol Psychiat 2009; 65:760-9
41. Weaver IC, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7: 847-54
42. Mill J, Tang T, Kaminsky Z, et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 2008; 82: 696-711. doi: 10.1016/j. ajhg.2008.01.008
43. Williams J, Spurlock G, McGuffin P, et al. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet 1996; 11:1294-6
44. Polesskaya OO, Sokolov BP. Differential expression of the "C" and "T" Alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res 2002; 67: 812-22
45. Chen J, Lipska BK, Halim N, et al. Functional analysis of genetic variation in catechol-o-methyltransferase (comt): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Human Genet 2004; 75:807-21
46. Weickert CS, Hyde TM, Lipska BK, et al. Reduced brainderived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 2003; 8:592-610
47. Berger SL. The complex language of chromatin regulation during transcription. Nature 2007; 447:407-12
48. Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylation in the human genome. Cell 2007; 129: 823-37
49. Akbarian S, Ruehl MG, Bliven E, et al. Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiat 2005; 62:829-40
50. Huang HS, Matevossian A, Whittle C. Prefrontal dysfunction in schizophrenia involves mixedlineage leukemia 1-regulated histone meth ylation at GABAergic gene promoters. J Neurosci 2007; 27:11254-62
51. Sharma RP, Grayson DR, Gavin DP. Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the national brain databank microarray collection. Schizophr Res 2008; 98:111-7